Bit Origin
BTOG
Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
SATO TECHNOLOGIES CORP
CCPUF
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 23.590
- -0.270-1.13%
Close Dec 23 16:00 ET
- 23.590
- 0.0000.00%
Post 16:45 ET
1.38BMarket Cap-15.73P/E (TTM)
23.845High22.790Low302.82KVolume23.740Open23.860Pre Close7.10MTurnover0.66%Turnover RatioLossP/E (Static)58.67MShares47.97052wk High8.07P/B1.08BFloat Cap18.54052wk Low--Dividend TTM45.73MShs Float318.750Historical High--Div YieldTTM4.42%Amplitude2.650Historical Low23.448Avg Price1Lot Size
Spyre Therapeutics News
Spyre Therapeutics Added to the Nasdaq Biotechnology Index
LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $50
BTIG Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $70
Promising Potential of Spyre Therapeutics' SPY002 Drives Buy Rating Amid Robust Anti-TL1A Market
Spyre Therapeutics Weakness After Teva Data a Buying Opportunity, Says BTIG
JonesTrading Initiates Spyre Therapeutics at Hold
Spyre Therapeutics Analyst Ratings
JonesTrading Initiates Spyre Therapeutics(SYRE.US) With Hold Rating
Spyre Therapeutics Announces Grants of Inducement Awards
Express News | Spyre Therapeutics Inc - Interim Data for Spy002 Molecules Expected in Q2 2025
Express News | Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-Life Extended Anti-Tl1a Antibodies
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
Jefferies, Goldman Sachs Among Managers for Spyre Offering >SYRE
Spyre Offering Expected to Close on or About November 20 >SYRE
Spyre: Underwritten Offering of 7,275,000 Shares Priced at $27.50 Each >SYRE
Express News | Spyre Therapeutics Inc Shares Down 1.2% in Late Trade at $28.33 Following Filing for Stock Offering
Spyre Therapeutics Faces Internal Control Challenges
Spyre Therapeutics Announces Proposed $200M Public Offering Of Its Common Stock And Pre-Funded Warrants
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.